| [1] | World Health Organization (1992) The ICD-10 Classification of Mental and Behavioral Disorders. Geneva: WHO. Available: http://www.who.int/classifications/apps/？icd/icd10online/. Accessed 1 August 2009.
|
| [2] | McGrath J, Saha S, Welham J, El SO, MacCauley C, et al. (2004) A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2: 13.
|
| [3] | Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLoS Med 2: e141. doi:10.1371/journal.pmed.0020141.
|
| [4] | McGrath J, Saha S, Chant D, Welham J (2008) Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30: 67–76.
|
| [5] | Aleman A, Kahn RS, Selten JP (2003) Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 60: 565–571.
|
| [6] | Saha S, Chant D, McGrath J (2007) A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64: 1123–1131.
|
| [7] | Newcomer JW, Hennekens CH (2007) Severe mental illness and risk of cardiovascular disease. JAMA 298: 1794–1796.
|
| [8] | Newcomer JW (2007) Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 68: Suppl 48–13.
|
| [9] | Ran MS, Chen EY, Conwell Y, Chan CL, Yip PS, et al. (2007) Mortality in people with schizophrenia in rural China: 10-year cohort study. Br J Psychiatry 190: 237–242.
|
| [10] | Brown S (1997) Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry 171: 502–508.
|
| [11] | Hyman SE, Chisholm D, Kessler RC, Patel V, Whiteford H (2006) Mental disorders. In: Jamision D, Breman JG, Measham A, Alleyne G, Claeson M, et al., editors. Disease control priorities in developing countries. New York: Oxford University Press. pp. 605–626.
|
| [12] | Jacob KS, Sharan P, Mirza I, Garrido-Cumbrera M, Seedat S, et al. (2007) Mental health systems in countries: where are we now? Lancet 370: 1061–1077.
|
| [13] | Kohn R, Saxena S, Levav I, Saraceno B (2004) Treatment gap in mental health care. Bull World Health Organ 82: 858–866.
|
| [14] | Patel V, Farooq S, Thara R (2007) What is the best approach to treating schizophrenia in developing countries? PLoS Med 4: e159. doi:10.1371/journal.pmed.0040159.
|
| [15] | Oosthuizen RAP, Emsley , Keyter N, Niehaus DJH, Koen L (2004) Duration of untreated psychosis and outcome in first-episode psychosis. Perspective from a developing country. Acta Psychiatr Scand 111: 214–219.
|
| [16] | Farooq S, Large M, Nielssen O, Waheed W (2009) The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta analysis. Schizophr Res 109: 15–23.
|
| [17] | McGlashan TH (1998) Early detection and intervention of schizophrenia: rationale and research. Br J Psychiatry Suppl 172: 3–6.
|
| [18] | Larsen TK, Friis S, Haahr U, Joa I, Johannessen JO, et al. (2001) Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 103: 323–334.
|
| [19] | Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, et al. (2003) Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res 60: 21–32.
|
| [20] | Salokangas RK, McGlashan TH (2008) Early detection and intervention of psychosis. A review. Nord J Psychiatry 62: 92–105.
|
| [21] | Marshall M, Rathbone J (2006) Early intervention for psychosis. Cochrane Database Syst Rev 4: CD004718.
|
| [22] | Killackey E, Yung AR (2007) Effectiveness of early intervention in psychosis. Curr Opin Psychiatry 20: 121–125.
|
| [23] | Cassidy CM, Schmitz N, Norman R, Manchanda R, Malla A (2008) Long-term effects of a community intervention for early identification of first-episode psychosis. Acta Psychiatr Scand 117: 440–448.
|
| [24] | Fitzgerald PB (2001) The role of early warning symptoms in the detection and prevention of relapse in schizophrenia. Aust N Z J Psychiatry 35: 758–764.
|
| [25] | Drake RJ, Lewis SW (2005) Early detection of schizophrenia. Curr Opin Psychiatry 18: 147–150.
|
| [26] | Melle I, Johannesen JO, Friis S, Haahr U, Joa I, et al. (2006) Early detection of the first episode of schizophrenia and suicidal behavior. Am J Psychiatry 163: 800–804.
|
| [27] | Hafner H, Maurer K (2006) Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry 5: 130–138.
|
| [28] | Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, et al. (1986) Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 16: 909–928.
|
| [29] | Cohen A, Patel V, Thara R, Gureje O (2008) Questioning an axiom: better prognosis for schizophrenia in the developing world? Schizophr Bull 34: 229–244.
|
| [30] | Eaton J, Agomoh AO (2008) Developing mental health services in Nigeria : the impact of a community-based mental health awareness programme. Soc Psychiatry Psychiatr Epidemiol 43: 552–558.
|
| [31] | Chatterjee S, Patel V, Chatterjee A, Weiss HA (2003) Evaluation of a community-based rehabilitation model for chronic schizophrenia in rural India. Br J Psychiatry 182: 57–62.
|
| [32] | Chatterjee S, Pilai A, Jain S, Cohen A, Patel V (2009) Outcomes of people with psychotic disorders in a community-based rehabilitation programme in rural India. Brit J Psychiatry. In press.
|
| [33] | Rummel C, Hamann J, Kissling W, Leucht S (2003) New generation antipsychotics for first episode schizophrenia. Cochrane Database Syst Rev 4: CD004410.
|
| [34] | Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, et al. (2008) Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371: 1085–1097.
|
| [35] | Gaebel W, Riesbeck M, W？lwer W, Klimke A, Eickhoff M, et al. (2007) Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry 68: 1763–1774.
|
| [36] | Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, et al. (2003) Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 28: 995–1003.
|
| [37] | Thornley B, Rathbone J, Adams CE, Awad G (2003) Chlorpromazine versus placebo for schizophrenia. Cochrane Database Syst Rev 2: CD000284.
|
| [38] | Joy CB, Adams CE, Lawrie SM (2006) Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev 4: CD003082.
|
| [39] | Leucht S, Arbter D, Engel RR, Kissling W, Davis JM (2009) How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Mol Psychiatry 14: 429–447.
|
| [40] | Geddes J, Freemantle N, Harrison P, Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 321: 1371–1376.
|
| [41] | Davis JM, Chen N, Glick ID (2003) A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 60: 553–564.
|
| [42] | Silva de Lima M, de Jesus Mari J, Breier A, Maria Costa A, Pondé de Sena E, et al. (2005) Quality of life in schizophrenia: a multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychotics. J Clin Psychiatry 66: 831–838.
|
| [43] | Mari JJ, Lima MS, Costa AN, Alexandrino N, Rodrigues-Filho S, et al. (2004) The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders. Eur Arch Psychiatry Clin Neurosci 254: 356–361.
|
| [44] | Leucht S, Corves C, Arbter D, Engel RR, Li C, et al. (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373: 31–41.
|
| [45] | Huf G, Alexander J, Allen MH, Raveendran NS (2009) Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev 8: CD005146.
|
| [46] | Raveendran NS, Tharyan P, Alexander J, Adams CE, TREC-India II Collaborative Group (2007) Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ 335: 865.
|
| [47] | Huf G, Coutinho ES, Adams CE, TREC Collaborative Group (2007) Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ 335: 869.
|
| [48] | Adams CE, Fenton MK, Quraishi S, David AS (2001) Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br J Psychiatry 179: 290–299.
|
| [49] | David A, Adams CE, Eisenbruch M, Quraishi S, Rathbone J (2005) Depot fluphenazine decanoate and enanthate for schizophrenia. Cochrane Database Syst Rev 1: CD000307.
|
| [50] | Brown GW, Carstairs GM, Wing JK (1962) Influence of family life on the course of schizophrenic illness. Br J Prev Soc Med 16: 55–68.
|
| [51] | Leff J, Kuipers L, Berkowitz R, Sturgeon D (1985) A controlled trial of social intervention in the families of schizophrenic patients: two year follow-up. Br J Psychiatry 146: 594–600.
|
| [52] | Pharoah F, Mari J, Rathbone J, Wong W (2006) Family intervention for schizophrenia. Cochrane Database Syst Rev 4: CD000088.
|
| [53] | Mari JJ, Streiner DL (1994) An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings. Psychol Med 24: 565–578.
|
| [54] | Chien WT, Chan SW, Thompson DR (2006) Effects of a mutual support group for families of Chinese people with schizophrenia: 18-month follow-up. Br J Psychiatry 189: 41–49.
|
| [55] | Chien WT, Wong KF (2007) A family psychoeducation group program for Chinese people with schizophrenia in Hong Kong. Psychiatr Serv 58: 1003–1006.
|
| [56] | Pekkala E, Merinder L (2002) Psychoeducation for schizophrenia. Cochrane Database Syst Rev 2: CD002831.
|
| [57] | Ran MS, Xiang MZ, Chan CL, Leff J, Simpson P, et al. (2003) Effectiveness of psychoeducational intervention for rural Chinese families experiencing schizophrenia-a randomised controlled trial. Soc Psychiatry Psychiatr Epidemiol 38: 69–75.
|
| [58] | Li Z, Arthur D (2005) Family education for people with schizophrenia in Beijing, China: randomised controlled trial. Br J Psychiatry 187: 339–345.
|
| [59] | Agara AJ, Onibi OE (2007) Effects of group psychoeducation (GPE) on compliance with scheduled clinic appointments in a neuro-psychiatric hospital in southwest Nigeria: a randomised control trial (RCT). Ann Acad Med Singapore 36: 272–275.
|
| [60] | Maneesakorn S, Robson D, Gournay K, Gray R (2007) An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs 16: 1302–1312.
|
| [61] | Zimmermann G, Favrod J, Trieu VH, Pomini V (2005) The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr Res 77: 1–9.
|
| [62] | Turkington D, Sensky T, Scott J, Barnes TR, Nur U, et al. (2008) A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: a five-year follow-up. Schizophr Res 98: 1–7.
|
| [63] | Startup M, Jackson MC, Evans KE, Bendix S (2005) North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: two-year follow-up and economic evaluation. Psychol Med 35: 1307–1316.
|
| [64] | Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, et al. (2002) Psychological treatments in schizophrenia: I. meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 32: 763–782.
|
| [65] | Bateman K, Hansen L, Turkington D, Kingdon D (2007) Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: results from a randomized controlled trial. Suicide Life Threat Behav 37: 284–290.
|
| [66] | Chafetz L, White M, Collins-Bride G, Cooper BA, Nickens J (2008) Clinical trial of wellness training: health promotion for severely mentally ill adults. J Nerv Ment Dis 196: 475–483.
|
| [67] | Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, et al. (2001) Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care. Health Technol Assess 5: 1–75.
|
| [68] | Marshall M, Lockwood A (2000) Assertive community treatment for people with severe mental disorders. Cochrane Database Syst Rev 2: CD001089.
|
| [69] | World Health Organization (2005) Atlas, mental health resources in the world. Geneva: WHO.
|
| [70] | Walley J, Lawn JE, Tinker A, de Francisco A, Chopra M, et al. (2008) Primary health care: making Alma-Ata a reality. Lancet 372: 1001–1007.
|
| [71] | Saxena S, Thornicroft G, Knapp M, Whiteford (2007) H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet 370: 878–889.
|
| [72] | Chisholm D, Flisher AJ, Lund C, Patel V, et al. Lancet Global Mental Health Group (2007) Scale up services for mental disorders: a call for action. Lancet 370: 1241–1252.
|
| [73] | Thara R, Padmavati R, Aynkran JR, John S (2008) Community mental health in India: a rethink. Int J Ment Health Syst 2: 11.
|
| [74] | Kermode M, Bowen K, Arole S, Joag K, Jorm AF (2009) Community beliefs about treatments and outcomes of mental disorders: a mental health literacy survey in a rural area of Maharashtra, India. Public Health 123: 476–483.
|
| [75] | Thornicroft G, Brohan E, Kassam A, Lewis-Holmes E (2008) Reducing stigma and discrimination: candidate interventions. Int J Ment Health Syst 2: 3.
|
| [76] | Eaton WW, Thara R, Federman E, Tien A (1998) Remission and relapse in schizophrenia: the Madras Longitudinal Study. J Nerv Ment Dis 186: 357–363.
|
| [77] | Razali SM, Mohd Yasin MA (2008) The pathway followed by psychotic patients to a tertiary health center in a developing country: a comparison with patients with epilepsy. Epilepsy Behav 13: 343–349.
|
| [78] | Srinivasan TN, Thara R (1997) How do men with schizophrenia fare at work? A follow-up study from India. Schizophr Res 25: 149–154.
|
| [79] | Bhugra D, McKenzie K (2003) Expressed emotion across cultures. Adv Psychiatr Treat 9: 342–348.
|
| [80] | Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, et al. (1992) Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 20: 1–97.
|
| [81] | Schulsinger F, Jablensky A (1991) The national mental health programme in the United Republic of Tanzania. A report from WHO and DANIDA. Acta Psychiatr Scand Suppl 364: 1–132.
|
| [82] | Susser E, Varma VK, Malhotra S, Conover S, Amador XF (1995) Delineation of acute and transient psychotic disorders in a developing country setting. Br J Psychiatry 167: 216–219.
|
| [83] | Malhotra S, Malhotra S (2003) Acute and transient psychotic disorders: comparison with schizophrenia. Curr Psychiatry Rep 5: 178–186.
|
| [84] | Somasundaram D, Thivakaran T, Bhugra D (2008) Possession states in Northern Sri Lanka. Psychopathology 41: 245–253.
|
| [85] | Limosin F, Loze JY, Philippe A, Casadebaig F, Rouillon F (2007) Ten-year prospective follow-up of the mortality by suicide in schizophrenic patients. Schizophr Res 94: 23–28.
|
| [86] | Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ (2005) Schizophrenia and suicide: systematic review of risk factors. Brit J Psychiatry 187: 9–27.
|
| [87] | Nordentoft M (2007) Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups. Dan Med Bull 54: 306–369.
|
| [88] | Carlborg A, Jokinen J, J？nsson EG, Nordstrom AL, N？rdstrom P (2008) Long-term suicide risk in schizophrenia spectrum psychoses: survival analysis by gender. Arch Suicide Res 12: 347–351.
|
| [89] | Lester D (2006) Sex differences in completed suicide by schizophrenic patients: a meta-analysis. Suicide Life Threat Behav 36: 50–56.
|
| [90] | Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, et al. (2006) A national study of violent behaviour in persons with schizophrenia. Arch Gen Psychiatry 63: 490–499.
|
| [91] | Meehan J, Flynn S, Hunt IM, Robinson J, Bickley H, et al. (2006) Perpetrators of homicide in schizophrenia: a national clinical survey in England and Wales. Psychiatr Serv 57: 1648–1651.
|
| [92] | Lambertti JS (2007) Understanding and preventing criminal recidivism among adults with psychotic disorders. Psychiatr Serv 58: 773–781.
|
| [93] | Volavka J, Laska EA, Baker S, Heisnser PC, Krivelevich I (1997) History of violent behavior and schizophrenia in different cultures. Brit J Psychiatry 171: 9–14.
|
| [94] | Temmingh HS, Oosthuizen PP (2008) Pathways to care and treatment delays in first and multi episode psychosis. Findings from a developing country. Soc Psychiatry Psychiatr Epidemiol 43: 727–735.
|
| [95] | Padmavathi R, Rajkumar S, Srinivasan TN (1998) Schizophrenic patients who were never treated–a study in an Indian urban community. Psychol Med 28: 1113–1117.
|
| [96] | Kurihara T, Kato M, Reverger R, I Gusti Rai Tirta , Kashima H (2005) Never-treated patients with schizophrenia in the developing country of Bali. Schizophr Res 15: 307–313.
|
| [97] | Chisholm D, Gureje O, Saldivia S, Villalón Calderón M, Wickremasinghe R, et al. (2008) Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis. Bull World Health Organ 86: 542–551.
|
| [98] | Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, et al. (2006) Advancement of global health: key messages from the Disease Control Priorities Project. Lancet 367: 1193–1208.
|
| [99] | Patel V, Araya R, Chatterjee S, Chisholm D, Cohen A, et al. (2007) Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet 370: 991–1005.
|
| [100] | Thornicroft G, Tansella M (2004) Components of a modern mental health service: a pragmatic balance of community and hospital care: overview of systematic evidence. Br J Psychiatry 185: 283–290.
|
| [101] | Nationa Institute for Health and Clinical Excellence (2009) NICE guidelines for schizophrenia. Available http://guidance.nice.org.uk/CG82. Accessed 22 August 2009.
|
| [102] | Royal Australian and New Zealand College of Psychiatrists (2005) RANZCP clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 39: 1–30.
|
| [103] | American Psychiatric Association (2006) Practice guideline for the treatment of patients with schizophrenia. Practice guideline for the treatment of psychiatric disorders. Washington (D.C.): APA.
|
